EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Slideshows|October 8, 2021
8 New Drugs Approved for Primary Care: Q3 2021
Author(s)Sydney Jennings
Advertisement
The third quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US Food and Drug Administration for conditions that are often seen in primary care. In the slides below, find details on the novel COVID-19 vaccine, a novel topical agent for atopic dermatitis, and 6 more.
For more information on FDA-approved medications from 2021, check out
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.
Advertisement
Advertisement
Trending on Patient Care Online
1
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
2
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
3
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5